Literature DB >> 7011357

Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double-blind study.

S Kaur, M Greaves, N Eftekhari.   

Abstract

The HI-antihistamine chlorpheniramine and the H2-antihistamine cimetidine, given alone and in combination, have been compared with placebo in twenty patients with factitious urticaria (dermographism), in a double-blind, randomized cross-over trial. Of these regimes, the combination was the only treatment which significantly reduced weal size, flare size and duration of weal, compared with placebo, although other treatments approached statistical significance. Continuation of the most effective of the four treatments in nineteen of the patients for a further 3 months without breaking the randomization code provided further evidence of the great effectivness of combined cimetidine and chlorpheniramine. No significant side effects were note.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011357     DOI: 10.1111/j.1365-2133.1981.tb00043.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Histamine H2-receptor antagonists for urticaria.

Authors:  Zbys Fedorowicz; Esther J van Zuuren; Nianfang Hu
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 2.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.

Authors:  E Paul; R H Bödeker
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.